Potential toxicity of a new sugar substitute in patients with liver disease.
D001218:Aspartame / Q000009:adverse effects*; D004151:Dipeptides / Q000009:adverse effects*; D006801:Humans; D008107:Liver Diseases / Q000150:complications* / Q000378:metabolism; D013549:Sweetening Agents / Q000009:adverse effects*
D004151:Dipeptides; D013549:Sweetening Agents; D001218:Aspartame